U.S. Communications Stock News

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Standard Motor Products, Inc.'s ( NYSE:SMP ) price-to-earnings (or "P/E") ratio of 11.7x might make it look like a buy...

Arlo Technologies, Inc. ( NYSE:ARLO ) shares have had a horrible month, losing 27% after a relatively good period...

Investors who take an interest in Fox Factory Holding Corp. ( NASDAQ:FOXF ) should definitely note that the CEO...

With a price-to-sales (or "P/S") ratio of 1.1x KVH Industries, Inc. ( NASDAQ:KVHI ) may be sending bullish signals at...

Insiders who bought US$584.8k worth of Claros Mortgage Trust, Inc.'s ( NYSE:CMTG ) stock at an average buy price of...

Key Insights Jiayin Group's significant insider ownership suggests inherent interests in company's expansion The...

Key Insights The considerable ownership by retail investors in Elicio Therapeutics indicates that they collectively...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

We feel now is a pretty good time to analyse Sky Harbour Group Corporation's ( NYSE:SKYH ) business as it appears the...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...

What are the early trends we should look for to identify a stock that could multiply in value over the long term...

LSB Industries, Inc. ( NYSE:LXU ), is not the largest company out there, but it saw a double-digit share price rise of...

Udemy, Inc. ( NASDAQ:UDMY ) shareholders that were waiting for something to happen have been dealt a blow with a 31...

Key Insights Significant control over Cardiff Oncology by individual investors implies that the general public has more...

Those following along with Sonos, Inc. ( NASDAQ:SONO ) will no doubt be intrigued by the recent purchase of shares by...

Key Insights Oxford Industries' estimated fair value is US$25.62 based on 2 Stage Free Cash Flow to Equity Oxford...

Phillip Frost, CEO and Chairman of OPKO Health, and Frost Gamma Investments Trust recently acquired US$737,747 worth of OPKO Health shares, significantly increasing Frost's ownership both directly and indirectly. This activity coincided with a downgrade from Jefferies, who shifted their rating from Buy to Hold due to concerns over flat sales guidance for Ngenla, a growth hormone product developed with Pfizer. To assess how insider buying by the CEO could influence OPKO Health’s outlook,...

Vanda Pharmaceuticals (VNDA) recently shared clinical trial results showing its drug tradipitant delivered clear benefits for patients experiencing nausea and vomiting from GLP-1 therapy with Wegovy. The trial met both key efficacy measures and reported no new safety concerns. See our latest analysis for Vanda Pharmaceuticals. Alongside the latest clinical win, Vanda’s share price recently surged 18% over the past week as investors digested upbeat trial news. However, momentum has been mixed;...

Wondering whether Maximus is a bargain or overvalued right now? If you are curious about the true worth of this stock, you are not alone. The share price has dipped 3.5% over the past week and is down 10.7% in the last month, but is still up 2.6% year-to-date. This gives mixed signals about investor sentiment and potential risk or growth. Maximus has recently been in the spotlight following several key contract announcements and expansion news. These updates related to government services...

LifeMD (LFMD) turned heads after releasing a mix of disappointing third-quarter earnings and a downward revision to its 2025 revenue and EBITDA forecasts, following its decision to divest its stake in WorkSimpli. See our latest analysis for LifeMD. LifeMD’s share price has tumbled in recent weeks, with a 1-day return of -2.44% capping off a much steeper 7-day decline of -21.3% as the market reacted to the lowered 2025 outlook and WorkSimpli divestiture. The one-year total shareholder return...

Premier (PINC) shares have been steady as the overall healthcare sector remains in focus. The company’s recent performance has gradually caught investors’ eyes, especially with year-to-date returns climbing over 31% and positive momentum observed over the past 3 months. See our latest analysis for Premier. Premier’s share price has surged this year, recording a robust 32% year-to-date gain and attracting attention for its strong momentum over the last quarter. While its long-term total...

The Regeneron Pharmaceuticals, Inc. ( NASDAQ:REGN ) share price has done very well over the last month, posting an...

Ever caught yourself wondering if Kaiser Aluminum is actually a bargain right now? You are not alone. Today's action is making that question even more interesting. Despite a dip of 5.6% in the last week, the stock is up 12.2% over the past month and has delivered a solid 27.7% year-to-date return. This shows there is real momentum, but also some volatility. Much of this movement has followed positive updates in the U.S. industrial and manufacturing sectors, where aluminum demand continues to...